1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Nephrectomy: new trials by email Literature Review of Nephrectomy trials Research Report on Nephrectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer Biopsy, Daratumumab, Laboratory Biomarker Analysis - Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 17 | 2018-05-29 | 2025-01-30 |
| Enzalutamide Before Surgery in Treating Patients With Kidney Cancer Enzalutamide, Laboratory Biomarker Analysis, Nephrectomy - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer | Early Phase 1 | Terminated | Rutgers, The State University of New Jersey | 3 | 2017-12-05 | 2021-09-16 |
Carcinoma, Renal Cell (2) · Urologic Neoplasms (1)
M.D. Anderson Cancer Center (1) · Rutgers, The State University of New Jersey (1)
United States (2)
Eric Singer (1) · Matthew T Campbell (1)
P30CA016672 (1), P30CA072720 (1)